CPC A61K 39/0241 (2013.01) [A61K 9/0019 (2013.01); A61K 39/12 (2013.01); A61K 39/39 (2013.01); A61P 31/20 (2018.01); A61K 2039/521 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/70 (2013.01)] | 17 Claims |
1. A method for the prevention and/or treatment of porcine enzootic pneumonia and/or Porcine Circovirus-Associated Diseases (PCVAD) comprising administering into the dermis of livestock in need thereof a single-dose combination vaccine comprising one or more antigens of Mycoplasma hyopneumoniae, one or more antigens of porcine circovirus, an adjuvant and pharmaceutically acceptable excipients and/or carriers, wherein the one or more antigens of porcine circovirus comprises the PCV2 ORF2 protein in an amount from 0.1 μg/dose to 10 μg/dose.
|